Health Care & Life Sciences » Biotechnology | Can-Fite Biopharma Ltd.

Can-Fite Biopharma Ltd. ADR | Income Statement

Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
643.00
652.00
2,936.00
13,733.90
Cost of Goods Sold (COGS) incl. D&A
57.00
47.00
-
-
-
-
Gross Income
57.00
47.00
-
-
-
-
SG&A Expense
31,255.00
27,726.00
25,621.00
33,792.00
28,501.00
33,148.30
EBIT
31,312.00
27,773.00
25,042.00
33,211.00
25,635.00
19,464.80
Unusual Expense
658.00
3,089.00
6,913.00
6,657.00
10,132.00
-
Non Operating Income/Expense
241.00
196.00
1,635.00
580.00
1,851.00
4,264
Interest Expense
-
58.00
76.00
105.00
102.00
64.70
Pretax Income
30,803.00
24,501.00
19,753.00
26,897.00
17,207.00
23,610.10
Income Tax
9.00
23.00
17.00
112.00
104.00
14.40
Consolidated Net Income
30,812.00
24,524.00
19,770.00
27,009.00
17,311.00
23,624.50
Net Income
29,049.00
23,759.00
18,726.00
26,532.00
17,269.00
23,624.50
Net Income After Extraordinaries
29,049.00
23,759.00
18,726.00
26,532.00
17,269.00
23,624.50
Net Income Available to Common
29,049.00
23,759.00
18,726.00
26,532.00
17,269.00
23,624.50
EPS (Basic)
2.12
1.35
0.82
0.96
0.53
0.61
Basic Shares Outstanding
13,712.00
17,546.00
22,953.00
27,710.00
32,525.00
38,902.20
EPS (Diluted)
2.12
1.35
0.82
0.96
0.53
0.61
Diluted Shares Outstanding
13,712.00
17,546.00
22,953.00
27,710.00
32,525.00
38,902.20
EBITDA
31,255.00
27,726.00
24,978.00
33,140.00
25,565.00
19,414.40
Non-Operating Interest Income
92.00
45.00
87.00
342.00
249.00
183.40
Minority Interest Expense
1,763.00
765.00
1,044.00
477.00
42.00
-

About Can-Fite Biopharma

View Profile
Address
Kiryat Matalon
Petach Tikva TA 4951778
Israel
Employees -
Website http://www.canfite.com
Updated 07/08/2019
Can-Fite BioPharma Ltd. operates as a clinical-stage biopharmaceutical company, which focuses on developing orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. Its products include pipeline drugs such as CF101, CF102 and CF602. The company offers drugs for the treatment of Psoriasis, Rheumatic Arthritis, Glaucoma, Uveitis, Crohn's disease, Osteoathritis, Hepatitis C, and Liver Cancer.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.